Format

Send to

Choose Destination
Nat Immunol. 2013 Feb;14(2):106-9. doi: 10.1038/ni.2473.

Personalizing medicine for autoimmune and inflammatory diseases.

Author information

1
Genentech, South San Francisco, California, USA. acc@gene.com

Abstract

Therapies that target molecular pathways do not provide uniform benefits for all patients at present. New transformative therapies for autoimmune and inflammatory diseases require greater molecular understanding of patient subsets and the ability to personalize targeted therapies for each subset.

PMID:
23334822
DOI:
10.1038/ni.2473
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center